Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

July 22, 2024 18:47 ET | Source: Robbins LLP

BOLT Stockholders Should Contact Shareholder Rights Law Firm Robbins LLP for Information About the Class Action Against Bolt Biotherapeutics, Inc.

Robbins LLP is Investigating Allegations that Bolt Therapeutics, Inc. (BOLT) Misled Investors Regarding the Viability of its New Drug Candidate
July 10, 2024 11:24 ET | Source: Robbins LLP

BOLT Class Action Alert: Robbins LLP Reminds Stockholders of the Lead Plaintiff Deadline in the Class Action Against Bolt Biotherapeutics, Inc.

Robbins LLP is Investigating Allegations that Bolt Therapeutics, Inc. (BOLT) Misled Investors Regarding the Viability of its New Drug Candidate
July 03, 2024 19:56 ET | Source: Robbins LLP

Shareholder Alert: Robbins LLP Informs Stockholders of the Class Action Filed Against Bolt Biotherapeutics, Inc. (BOLT)

Robbins LLP is Investigating Allegations that Bolt Therapeutics, Inc. (BOLT) Misled Investors Regarding the Viability of its New Drug Candidate